Did you know? NeuroQuant Provides Color-Coded Segmentations for Easy Structure Review

In addition to providing automated and fast brain structure segmentation, NeuroQuant produces color-coded overlays in which each color represents a different region of interest. The color-coding allows physicians to effortlessly review the segmentation. Also, for physicians wanting to examine a structure or structures that are not on the NeuroQuant output report, they can easily locate the structure by its associated color.

The images below show an MR T1-weighted images (left) and NeuroQuant segmentation overlaying a T1-weighted image (right). The table below the images provides the structure and associated color.

Cortechs.ai | Did you know? NeuroQuant Provides Color-Coded Segmentations for Easy Structure Review

Segmented Color-Blended Volumes Cortechs.ai | Did you know? NeuroQuant Provides Color-Coded Segmentations for Easy Structure Review

To learn more about the importance of using quantitative volumetric imaging for brain MRI in clinical practice, check out our latest Cortechs.ai white paper.

To see how you can use automated quantitative analysis to more objectively analyze your patients’ data, visit our website.

More Resources

09/18/2026

What a Head CT Can and Can’t Tell You About a Concussion

For Concussion Awareness Day, learn how quantitative CT analysis can help measure subtle structural changes and support follow-up after traumatic brain injury.

09/09/2026

Prostate Cancer Awareness Month: Finding the Cancer That Matters

How quantitative MRI can bring greater clarity to decisions across the prostate cancer journey.

09/01/2026

Quantifying What Matters: Advancing Alzheimer’s Imaging with NeuroQuant®

Explore how quantitative imaging is transforming Alzheimer’s care, from structural volumetrics and amyloid PET to treatment monitoring with NeuroQuant®.

08/19/2026

Brain Metastases Imaging Insights from SNO/ASCO 2026

Explore key insights from SNO/ASCO 2026 on brain metastases imaging, including lesion tracking, volumetric analysis, SRS workflows, and automated segmentation.

08/18/2026

Cortechs.ai Announces FDA Clearance for NeuroQuant® PET: Advancing Molecular Imaging for Cognitive Impairment

NeuroQuant® PET receives FDA 510(k) clearance, advancing quantitative PET imaging for cognitive impairment.

08/04/2026

Cortechs.ai Expands European CE Marking Across AI Imaging Platform, Accelerating Global Growth

Cortechs.ai expands EU CE Marking for the latest NeuroQuant®, NeuroQuant® Brain Tumor, and OnQ™ Prostate, advancing global AI imaging innovation
Scroll to Top